The Center for Drug Evaluation & Research has “turned the corner” on net gains in staffing during the past year, acting CDER Director Patrizia Cavazzoni said during a briefing hosted by the Alliance for a Stronger FDA on 16 October.
US FDA Drug Review Hiring Doing Well Despite Pandemic
CDER has ‘turned the corner’ on hiring during 2020, acting Director tells stakeholders – though the added workload from COVID-19 makes that hard to see.
More from Agency Leadership
More from Pink Sheet
• By
Pink Sheet reporter and editors discuss how staff may not be the only thing the FDA could lose with the latest layoffs announced by the Health and Human Services Department.
• By
The European Medicines Agency has recommended five drugs for EU-wide approval , including Averoa’s Xoanacyl for concomitant hyperphosphatemia. Two companies have withdrawn their marketing authorization applications.
• By
Eli Lilly’ will request a re-examination after the European Medicines Agency declined to recommend its Alzheimer’s disease drug Kisunla for EU approval.